Pulmonary affectation of vasculitis

Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archivos de bronconeumología (English ed.) 2012-11, Vol.48 (11), p.410-418
Hauptverfasser: Martín-Suñé, Natalia, Ríos-Blanco, Juan José
Format: Artikel
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 418
container_issue 11
container_start_page 410
container_title Archivos de bronconeumología (English ed.)
container_volume 48
creator Martín-Suñé, Natalia
Ríos-Blanco, Juan José
description Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis.
doi_str_mv 10.1016/j.arbres.2012.04.007
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1237093220</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1237093220</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-e2ef61303ab497343340f9ca25dff9b91d27b15aa69f4d4bf1a89715b1a74a783</originalsourceid><addsrcrecordid>eNo1j01LxDAUAIMg7rr6D0QKXry0vveSJs1RFleFBT3ouby0CXTpl00r-O9dcD3NZRgYIW4QMgTUD4eMJzf5mBEgZaAyAHMm1pgbmxKSXYnLGA8AWiPihVgR6YI0qLW4e1_abuh5-kk4BF_NPDdDnwwh-eZYLW0zN_FKnAduo78-cSM-d08f25d0__b8un3cpyMqnFNPPmiUINkpa6SSUkGwFVNeh2CdxZqMw5xZ26Bq5QJyYQ3mDtkoNoXciPu_7jgNX4uPc9k1sfJty70fllgiSQNWEsFRvT2pi-t8XY5T0x0fyv8x-QtfW053</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1237093220</pqid></control><display><type>article</type><title>Pulmonary affectation of vasculitis</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Martín-Suñé, Natalia ; Ríos-Blanco, Juan José</creator><creatorcontrib>Martín-Suñé, Natalia ; Ríos-Blanco, Juan José</creatorcontrib><description>Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis.</description><identifier>EISSN: 1579-2129</identifier><identifier>DOI: 10.1016/j.arbres.2012.04.007</identifier><identifier>PMID: 22682604</identifier><language>eng ; spa</language><publisher>Spain</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy ; Antibodies, Monoclonal, Murine-Derived - therapeutic use ; Combined Modality Therapy ; Granuloma, Respiratory Tract - etiology ; Granuloma, Respiratory Tract - pathology ; Granulomatosis with Polyangiitis - complications ; Granulomatosis with Polyangiitis - pathology ; Granulomatosis with Polyangiitis - therapy ; Hemorrhage - etiology ; Humans ; Immunoglobulins, Intravenous - therapeutic use ; Immunosuppressive Agents - therapeutic use ; Lung - blood supply ; Lung Diseases - etiology ; Lung Diseases - pathology ; Methotrexate - therapeutic use ; Plasmapheresis ; Rituximab ; Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors ; Vasculitis - classification ; Vasculitis - complications ; Vasculitis - drug therapy ; Vasculitis - pathology ; Vasculitis - therapy</subject><ispartof>Archivos de bronconeumología (English ed.), 2012-11, Vol.48 (11), p.410-418</ispartof><rights>Copyright © 2012 SEPAR. Published by Elsevier España, S.L. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22682604$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martín-Suñé, Natalia</creatorcontrib><creatorcontrib>Ríos-Blanco, Juan José</creatorcontrib><title>Pulmonary affectation of vasculitis</title><title>Archivos de bronconeumología (English ed.)</title><addtitle>Arch Bronconeumol</addtitle><description>Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications</subject><subject>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology</subject><subject>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy</subject><subject>Antibodies, Monoclonal, Murine-Derived - therapeutic use</subject><subject>Combined Modality Therapy</subject><subject>Granuloma, Respiratory Tract - etiology</subject><subject>Granuloma, Respiratory Tract - pathology</subject><subject>Granulomatosis with Polyangiitis - complications</subject><subject>Granulomatosis with Polyangiitis - pathology</subject><subject>Granulomatosis with Polyangiitis - therapy</subject><subject>Hemorrhage - etiology</subject><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Lung - blood supply</subject><subject>Lung Diseases - etiology</subject><subject>Lung Diseases - pathology</subject><subject>Methotrexate - therapeutic use</subject><subject>Plasmapheresis</subject><subject>Rituximab</subject><subject>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><subject>Vasculitis - classification</subject><subject>Vasculitis - complications</subject><subject>Vasculitis - drug therapy</subject><subject>Vasculitis - pathology</subject><subject>Vasculitis - therapy</subject><issn>1579-2129</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j01LxDAUAIMg7rr6D0QKXry0vveSJs1RFleFBT3ouby0CXTpl00r-O9dcD3NZRgYIW4QMgTUD4eMJzf5mBEgZaAyAHMm1pgbmxKSXYnLGA8AWiPihVgR6YI0qLW4e1_abuh5-kk4BF_NPDdDnwwh-eZYLW0zN_FKnAduo78-cSM-d08f25d0__b8un3cpyMqnFNPPmiUINkpa6SSUkGwFVNeh2CdxZqMw5xZ26Bq5QJyYQ3mDtkoNoXciPu_7jgNX4uPc9k1sfJty70fllgiSQNWEsFRvT2pi-t8XY5T0x0fyv8x-QtfW053</recordid><startdate>201211</startdate><enddate>201211</enddate><creator>Martín-Suñé, Natalia</creator><creator>Ríos-Blanco, Juan José</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201211</creationdate><title>Pulmonary affectation of vasculitis</title><author>Martín-Suñé, Natalia ; Ríos-Blanco, Juan José</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-e2ef61303ab497343340f9ca25dff9b91d27b15aa69f4d4bf1a89715b1a74a783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; spa</language><creationdate>2012</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications</topic><topic>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology</topic><topic>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy</topic><topic>Antibodies, Monoclonal, Murine-Derived - therapeutic use</topic><topic>Combined Modality Therapy</topic><topic>Granuloma, Respiratory Tract - etiology</topic><topic>Granuloma, Respiratory Tract - pathology</topic><topic>Granulomatosis with Polyangiitis - complications</topic><topic>Granulomatosis with Polyangiitis - pathology</topic><topic>Granulomatosis with Polyangiitis - therapy</topic><topic>Hemorrhage - etiology</topic><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Lung - blood supply</topic><topic>Lung Diseases - etiology</topic><topic>Lung Diseases - pathology</topic><topic>Methotrexate - therapeutic use</topic><topic>Plasmapheresis</topic><topic>Rituximab</topic><topic>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</topic><topic>Vasculitis - classification</topic><topic>Vasculitis - complications</topic><topic>Vasculitis - drug therapy</topic><topic>Vasculitis - pathology</topic><topic>Vasculitis - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martín-Suñé, Natalia</creatorcontrib><creatorcontrib>Ríos-Blanco, Juan José</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Archivos de bronconeumología (English ed.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martín-Suñé, Natalia</au><au>Ríos-Blanco, Juan José</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pulmonary affectation of vasculitis</atitle><jtitle>Archivos de bronconeumología (English ed.)</jtitle><addtitle>Arch Bronconeumol</addtitle><date>2012-11</date><risdate>2012</risdate><volume>48</volume><issue>11</issue><spage>410</spage><epage>418</epage><pages>410-418</pages><eissn>1579-2129</eissn><abstract>Respiratory tract affectation is frequent in some types of vasculitis, fundamentally in those associated with anti-neutrophil cytoplasmic antibodies (ANCA). The clinical, radiological and histopathological presentation is also heterogeneous and conditions the evolution. It is therefore necessary to establish an early diagnosis based on the symptoms because, thanks to new treatments, and despite them being potentially serious diseases, their prognosis has improved considerably in recent years. The present paper updates the diagnosis and the new therapeutic options for pulmonary vasculitis.</abstract><cop>Spain</cop><pmid>22682604</pmid><doi>10.1016/j.arbres.2012.04.007</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1579-2129
ispartof Archivos de bronconeumología (English ed.), 2012-11, Vol.48 (11), p.410-418
issn 1579-2129
language eng ; spa
recordid cdi_proquest_miscellaneous_1237093220
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adrenal Cortex Hormones - therapeutic use
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - pathology
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - therapy
Antibodies, Monoclonal, Murine-Derived - therapeutic use
Combined Modality Therapy
Granuloma, Respiratory Tract - etiology
Granuloma, Respiratory Tract - pathology
Granulomatosis with Polyangiitis - complications
Granulomatosis with Polyangiitis - pathology
Granulomatosis with Polyangiitis - therapy
Hemorrhage - etiology
Humans
Immunoglobulins, Intravenous - therapeutic use
Immunosuppressive Agents - therapeutic use
Lung - blood supply
Lung Diseases - etiology
Lung Diseases - pathology
Methotrexate - therapeutic use
Plasmapheresis
Rituximab
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Vasculitis - classification
Vasculitis - complications
Vasculitis - drug therapy
Vasculitis - pathology
Vasculitis - therapy
title Pulmonary affectation of vasculitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A30%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pulmonary%20affectation%20of%20vasculitis&rft.jtitle=Archivos%20de%20bronconeumologi%CC%81a%20(English%20ed.)&rft.au=Mart%C3%ADn-Su%C3%B1%C3%A9,%20Natalia&rft.date=2012-11&rft.volume=48&rft.issue=11&rft.spage=410&rft.epage=418&rft.pages=410-418&rft.eissn=1579-2129&rft_id=info:doi/10.1016/j.arbres.2012.04.007&rft_dat=%3Cproquest_pubme%3E1237093220%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1237093220&rft_id=info:pmid/22682604&rfr_iscdi=true